Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
A Massachusetts federal judge on Friday sanctioned a whistleblower’s attorneys for misconduct in a suit alleging false claims to Medicare by tossing the case, ruling that the complaint wouldn’t have survived the dismissal phase had it not relied on unethically sourced evidence.
The Tenth Circuit on Friday affirmed an Oklahoma federal judge’s decision ordering a lawyer to give lectures at the University of Tulsa law school, finding that the lower court had properly found that he mishandled a lawsuit over unwanted sales calls he claimed came from a supplement company.
A woman who alleges her daily use of Johnson & Johnson’s talcum powder products over decades caused her to develop ovarian tumors testified for a Missouri jury on Friday, saying she wouldn’t have used the company’s products had they included any warnings about cancer risks.
The Eleventh Circuit on Thursday upheld a 20-year sentence for a doctor charged with 92 federal counts arising from his participation in two Georgia pain management clinics that purportedly operated as “pill mills,” saying he failed to prove error in the trial court's handling of the case.
Retrophin Inc.’s cooperation with the government in the criminal case against Martin Shkreli and the company’s separate action against its former CEO amounts to a “wholesale waiver” of privilege over communications key to Shkreli’s defense, his attorneys told a New York federal court.